Skip to search formSkip to main contentSkip to account menu

alipogene tiparvovec

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A Long-Term (up to 6 years) Retrospective Analysis of Gene Therapy with Alipogene Tiparvovec and its Effect on Lipoprotein Lipase Deficiency (LPLD)-Induced Pancreatitis.
2016
2016
Gene therapy: Case study on the first lipoprotein lipase deficiency patient treated with Alipogene Tiparvovec in Germany
2015
2015
Alipogene Tiparvovec: Gene Therapy for Familial Lipoprotein Lipase Deficiency
2015
2015
New era in gene therapy: end of the beginning
Despite recent progress in effective biologic drugs, such as monoclonal antibodies, there are still a number of diseases for… 
2014
2014
Gene therapy with alipogene tiparvovec (glybera®) for the prevention of LPLD induced pancreatitis: Follow-up data suggests long-term clinical benefit
2013
2013
Monographs: Alipogene tiparvovec for the treatment of lipoprotein lipase deficiency.
2010
2010
Gene Therapy With Alipogene Tiparvovec Results in Enhanced Post-prandial Clearance of Chylomicrons in LPLD Patients
2010
2010
Alipogene Tiparvovec Development: An Example of an Application of Gene Therapy Application Possibilities
2010
2010
Alipogene Tiparvovec May Prevent Pancreatitis From Chylomicronaemia in Lipoprotein Lipase Deficiency (LPLD)
2009
2009
Abstract 2093: AAV1-LPLS447X Gene Therapy With Alipogene Tiparvovec Prevents Pancreatitis in Lipoprotein Lipase Deficiency
Introduction: Lipoprotein lipase deficiency (LPLD) is the most common cause of familial chylomicronemia and severe… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)